9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
39 hedge funds and large institutions have $7.38M invested in 9 Meters Biopharma in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 13 closing their positions.
240% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 5
74% more call options, than puts
Call options by funds: $80K | Put options by funds: $46K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 45 → 39 (-6)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
63% less capital invested
Capital invested by funds: $20.1M → $7.38M (-$12.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$729K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$529K |
| 3 |
BlackRock
New York
|
+$282K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$124K |
| 5 |
Bank of New York Mellon
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
-$674K |
| 2 |
Millennium Management
New York
|
-$475K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$365K |
| 4 |
DWM
Dynasty Wealth Management
St. Petersburg,
Florida
|
-$243K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$195K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| – | -$4.13K | -30 | Closed |
|
|
IP
52
Intellectus Partners
San Francisco,
California
| – | -$1K | -5 | Closed |
|
NMTR Hedge Fund Activity: Q4 2018 in Review
39 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q4 2018, worth a combined $7.38M — down 63% from $20.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NMTR and 7 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 17 added.
The largest buyer was Vanguard Group, adding an estimated $729K. The largest seller was Jefferies Group, exiting entirely with an estimated $674K sold.
- 39 institutional investors held 9 Meters Biopharma (NMTR) as of Q4 2018, down from 45 in Q3 2018.
- Funds reported $7.38M of 9 Meters Biopharma stock for Q4 2018, down 63% quarter-over-quarter.
- 7 funds opened new 9 Meters Biopharma positions in Q4 2018 and 13 closed out, a net change of -6 holders.
- The largest 9 Meters Biopharma buyer in Q4 2018 was Vanguard Group, an estimated $729K added.
- The largest 9 Meters Biopharma seller in Q4 2018 was Jefferies Group, an estimated $674K sold.
Based on aggregated 13F filings for Q4 2018.